Literature DB >> 31005203

Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies.

Zhiyong Yang1, Yu Chang2, Kristy K Brock3, Guillaume Cazoulat3, Eugene J Koay4, Albert C Koong4, Joseph M Herman4, Peter C Park5, Falk Poenisch5, Qin Li2, Kunyu Yang2, Gang Wu2, Brian Anderson3, Andrea N Ohrt3, Yupeng Li5, X Ronald Zhu5, Xiaodong Zhang5, Heng Li6.   

Abstract

PURPOSE: To evaluate the effect of setup uncertainties including uncertainties between different breath holds (BH) and inter-fractional anatomical changes under CT-guided BH with intensity-modulated proton therapy (IMPT) in patients with liver cancer. METHODS AND MATERIALS: This retrospective study considered 17 patients with liver tumors who underwent feedback-guided BH (FGBH) IMRT treatment with daily CT-on-rail imaging. Planning CT images were acquired at simulation using FGBH, and FGBH CT-on-rail images were also acquired prior to each treatment. Selective robust IMPT plans were generated using planning CT and re-calculated on each daily CT-on-rail image. Subsequently, the fractional doses were deformed and accumulated onto the planning CT according to the deformable image registration between daily and planning CTs. The doses to the target and organs at risk (OARs) were compared between IMRT, planned IMPT, and accumulated IMPT doses.
RESULTS: For IMPT plans, the mean of D98% of CTV for all 17 patients was slightly reduced from the planned dose of 68.90 ± 1.61 Gy to 66.48 ± 1.67 Gy for the accumulated dose. The target coverage could be further improved by adjusting planning techniques. The dose-volume histograms of both planned and accumulated IMPT doses showed better sparing of OARs than that of the IMRT.
CONCLUSIONS: IMPT with FGBH and CT-on-rail guidance is a robust treatment approach for liver tumor cases.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accumulated dose; Intensity-modulated proton therapy; Liver cancer

Mesh:

Year:  2019        PMID: 31005203     DOI: 10.1016/j.radonc.2019.01.028

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  Adaptive proton therapy.

Authors:  Harald Paganetti; Pablo Botas; Gregory C Sharp; Brian Winey
Journal:  Phys Med Biol       Date:  2021-11-15       Impact factor: 3.609

2.  Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System.

Authors:  Yu Chang; Hong-Yuan Liu; Zhi-Wen Liang; Xin Nie; Jing Yang; Gang Liu; Qin Li; Zhi-Yong Yang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

3.  Evaluation of Intensity- and Contour-Based Deformable Image Registration Accuracy in Pancreatic Cancer Patients.

Authors:  Yoshiki Kubota; Masahiko Okamoto; Yang Li; Shintaro Shiba; Shohei Okazaki; Shuichiro Komatsu; Makoto Sakai; Nobuteru Kubo; Tatsuya Ohno; Takashi Nakano
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639

4.  Evaluation of OAR dose sparing and plan robustness of beam-specific PTV in lung cancer IMRT treatment.

Authors:  Yu Chang; Feng Xiao; Hong Quan; Zhiyong Yang
Journal:  Radiat Oncol       Date:  2020-10-17       Impact factor: 3.481

5.  Evaluating Proton Dose and Associated Range Uncertainty Using Daily Cone-Beam CT.

Authors:  Heng Li; William T Hrinivich; Hao Chen; Khadija Sheikh; Meng Wei Ho; Rachel Ger; Dezhi Liu; Russell Kenneth Hales; Khinh Ranh Voong; Aditya Halthore; Curtiland Deville
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.